Pfizer, Inc. (PFE): Price and Financial Metrics

Pfizer, Inc. (PFE)

Today's Latest Price: $37.23 USD

0.70 (1.92%)

Updated Nov 27 5:04pm

Add PFE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PFE Stock Summary

  • Pfizer Inc's market capitalization of $206,939,105,381 is ahead of 99.37% of US-listed equities.
  • PFE's went public 34.93 years ago, making it older than 92.95% of listed US stocks we're tracking.
  • In terms of volatility of its share price, PFE is more volatile than merely 2.4% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Pfizer Inc, a group of peers worth examining would be NVS, MRK, ABT, NFLX, and T.
  • PFE's SEC filings can be seen here. And to visit Pfizer Inc's official web site, go to

PFE Stock Price Chart Interactive Chart >

Price chart for PFE

PFE Price/Volume Stats

Current price $37.23 52-week high $41.99
Prev. close $36.53 52-week low $27.88
Day low $36.75 Volume 25,276,900
Day high $37.26 Avg. volume 30,374,693
50-day MA $36.82 Dividend yield 4.08%
200-day MA $35.98 Market Cap 206.94B

Pfizer, Inc. (PFE) Company Bio

Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel, among others. The company was founded in 1849 and is based in New York, New York.

PFE Latest News Stream

Event/Time News Detail
Loading, please wait...

PFE Latest Social Stream

Loading social stream, please wait...

View Full PFE Social Stream

Latest PFE News From Around the Web

Below are the latest news stories about Pfizer Inc that investors may wish to consider to help them evaluate PFE as an investment opportunity.

Sertraline Hydrochloride Tablet Market to Record Significant Revenue Growth during the Forecast Period 2020–2025 | PIDI, Cy Pharm, Pfizer, Accord-Healthcare, Exelan, Greenstone, Cipla, Lupins

This report provides in-depth study on the current state of the Global Sertraline Hydrochloride Tablet Market 2020-2025. Key players in the Global Sertraline Hydrochloride Tablet Market have been identified through the secondary research and their market share has been determined

OpenPR | October 2, 2020

Insulin Market is Forecast To Reach USD 35.74 Billion By 2027 | Sanofi, Eli Lily and Company, ADOCIA, Julphar, Pfizer, Inc

The latest updated report on the Global Insulin Market added by Reports and Data presents a comprehensive analysis of the industry size, revenue forecast, regional spectrum of the business vertical, and further elaborates on the major hurdles, challenges, and latest

OpenPR | October 2, 2020

Fibromyalgia Drugs Market Capacity, Production, Revenue, Price and Gross Margin, Industry Analysis & Forecast by 2026| Pfizer, Eli Lilly, Actavis

Fibromyalgia Drugs Market is expected to grow significantly over next few years and generate considerable market for Fibromyalgia Drugs. Market Report Expert has recently published a research report titled, “ Fibromyalgia Drugs Market Outlook and Statistics, 2020-2026". The report has been

OpenPR | October 2, 2020

Trump at high risk of serious Covid-19 illness - STAT

Pfizer CEO Albert Bourla told employees he was disappointed that its work developing a Covid-19 vaccine has been politicized.

STAT News | October 2, 2020

Report: Pfizer CEO tell employees COVID-19 vaccine will move only at 'speed of science'

Shares of Pfizer Inc. undefined were down 0.1% in premarket trading on Friday, the day after the Associated Press reported that CEO Albert Bourla had…

MarketWatch | October 2, 2020

Read More 'PFE' Stories Here

PFE Price Returns

1-mo 6.01%
3-mo 1.99%
6-mo 5.03%
1-year 0.60%
3-year 14.51%
5-year 36.47%
YTD -1.10%
2019 -6.91%
2018 24.82%
2017 15.90%
2016 4.42%
2015 7.09%

PFE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8184 seconds.